Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents
Kidney injury caused by anticancer agents is a common problem that can interfere with and affect the dose intensity of anticancer therapy, thus restricting patient survival. Recent advances in targeted and immunotherapeutic agents have transformed the landscape of medical oncology, and these agents...
Saved in:
Main Author: | Min Hee Hong (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review
by: Saeid Heidari-Soreshjani, et al.
Published: (2017) -
Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in countering nephrotoxicity in rats induced by the chemotherapeutic agent cisplatin
by: Salma Malik, et al.
Published: (2016) -
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
by: RamaRao Malla, et al.
Published: (2022) -
Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria
by: Xingyi Qu, et al.
Published: (2024) -
Drug Nephrotoxicity in Family Doctor Practice
by: Violetta Kruczyńska-Kisły, et al.
Published: (2019)